E-mail:info@bkebdp.com  Skype:reallant   Whatsapp:+86 15853013375

Home > Products > others > Vinorelbine tartrate cas no:125317-39-7

Vinorelbine tartrate cas no:125317-39-7

Vinorelbine tartrate cas no:125317-39-7

  • Category: others
  • Views:334
  • High purity
  • factory supply
  • reasonable price
  • fast shipping
  • Product description:Vinorelbine tartrate cas no:125317-39-7 in stock factory supply sample available
  • Contact now

Please read words below:

1.you can send a message using our website,or you can contact us directly by email.we will reply as soon as possible.

2. We have a large scale manufacturing facility and offer big discounts for wholesale buyers.

3.We guarantee the qulity of our products but would encourage you to order a sample first to make sure it's the right product for you and that you can be reassured of the quality of our products and our highly qualified chemists.

4.Payment methods,we prefer WU,Moneygram and Bitcoin but may accept other cryptocurrencies.

5. Packages will be shipped within 24 hours after confirmed payment. We have been operating for many years and are very experienced with secure shipping methods. We are sure that you will be pleased with our postage and packaging.

6. We pride ourself on making sure our customers receive our product and get what they have paid for. For any reason the shipment has been lost then we will resend at no extra charge.


7. We are looking for repeat custom and mutely beneficial business arrangements, we value our customers and will try to do anything we can to accommodate your specific needs.

Vinorelbine is an anti-mitotic chemotherapy drug that is used in the treatment of several types of malignancies, including breast cancer and non-small cell lung cancer (NSCLC). It was initially approved in the USA in 1990's for the treatment of NSCLC.


It is a third-generation vinca alkaloid. The introduction of third-generation drugs (vinorelbine, gemcitabine, taxanes) in platinum combination improved survival of patients with advanced NSCLC, with very similar results from the various drugs. Treatment toxicities are considerable in the combination treatment setting.


A study was done on the clearance rate of vinorelbine on individuals with various single polymorphonuclear mutations. It was found that there was 4.3-fold variation in vinorelbine clearance across the cohort, suggesting a strong influence of genetics on the clearance of this drug.



Scan the qr codeClose
the qr code